Table 2 Seroreactivity in association with benign condylomatous warts: Cumulative antibody responses to low risk (HPV-6, -11) or high risk (HPV-16, -18, -31) VLPs in HIV-positive versus HIV-negative men

antibodies to low risk HPV

10 (40 %)⁺

14 (25.4 %)⁺

antibodies to high risk HPV

16 (64 %)*

7 (12.7 %)*

Heterosexuals without warts:

HIV-positive (n = 93)

HIV-negative (n = 98)

antibodies to low risk HPV

15 (16.1 %)

12 (12.2 %)

antibodies to high risk HPV

29 (31.1 %)**

11 (11.2 %)**

Homosexuals without warts:

HIV-positive (n = 50)

-

antibodies to low risk HPV

15 (30%)

-

antibodies to high risk HPV

21 (42%)

-

Male blood donors:

-

HIV-negative (n = 100, STD history unknown)

antibodies to low risk HPV

-

9 (9 %)

antibodies to high risk HPV

-

10 (10 %)